Injectable contraception: what should the longest interval be for reinjections?

Contraception

Volumn 77, Issue 6, 2008, Pages 410-414

  Steiner, Markus J ^a   Kwok, Cynthia ^a   Stanback, John ^a   Byamugisha, Josaphat K ^b   Chipato, Tsungai ^c   Magwali, Thulani ^c   Mmiro, Francis ^b   Rugpao, Sungwal ^d   Sriplienchan, Somchai ^a   Morrison, Charles ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Contraception; Contraceptive counseling; Contraceptive failure; DMPA; Reinjection interval

Indexed keywords

GESTAGEN; INJECTABLE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RISK ASSESSMENT; THAILAND; UGANDA; WORLD HEALTH ORGANIZATION; ZIMBABWE;

ADULT; COHORT STUDIES; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDROXYPROGESTERONE; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; THAILAND; TREATMENT OUTCOME; UGANDA; ZIMBABWE;

EID: 43049168775     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.01.017     Document Type: Article

References (26)

1. Seiber E.E., Bertrand J.T., and Sullivan T.M. Changes in contraceptive method mix in developing countries. Int Fam Plan Perspect 33 (2007) 117-123
2. Trussell J. Contraceptive efficacy. In: Hatcher R.A., Trussell J., Nelson A.N., Cates Jr. W., Stewart F.H., and Kowal D. (Eds). Contraceptive technology. 19th revised ed. (2007), Ardent Media, Inc., New York 747-756
3. Steiner M.J., Kwok C., Dominik R., et al. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, Zimbabwe, and Thailand. Obstet Gynecol 110 (2007) 1003-1009
4. Baumgartner J.N., Morroni C., Mlobeli R.D., et al. Timeliness of contraceptive reinjections in South Africa and its relation to unintentional discontinuation. Int Fam Plan Perspect 33 (2007) 66-74
5. World Health Organization. Selected practice recommendations for contraceptive use. 2nd ed. (2004), WHO, Geneva
6. Ortiz A., Hirol M., Stanczyk F.Z., Goebelsmann U., and Mishell D.R. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 44 (1977) 32-38
7. Fotherby K., and Howard G. Return of fertility in women discontinuing injectable contraceptives. J Obstet Gynaecol 6 Suppl 2 (1986) S110-S115
8. Bassol S., Garza-Flores J., et al. Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses. Fertil Steril 42 (1984) 216-222
9. Lan P.T., Aedo A.R., Landgren B.M., Johannisson E., and Diczfalusy E. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. Contraception 29 (1984) 1-18
10. Saxena B.N., Dusitsin N., Tankeyoon M., and Chaudhury R.R. Return of ovulation after the cessation of depot-medroxyprogesterone acetate treatment in Thai women. J Med Assoc Thai 63 (1980) 66-69
11. Garza-Flores J., Cardenas S., Rodriguez V., Cravioto M.C., Diaz-Sanchez V., and Perez-Palacios G. Return to ovulation following the use of long-acting injectable contraceptives: a comparative study. Contraception 31 (1985) 361-366
12. Grimes D.A., and Schulz K.F. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 105 5 Pt 1 (2005) 1114-1118
13. Brache V., Alvarez-Sanchez F., Faundes A., Tejada A.S., and Cochon L. Ovarian endocrine function through five years of continuous treatment with Norplant subdermal contraceptive implants. Contraception 41 (1990) 169-177
14. Morrison C.S., Richardson B.A., Mmiro F., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007) 85-95
15. Clopper C., and Pearson S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26 (1934) 404-413
16. Garza-Flores J., Rodriguez V., Perez-Palacios G., et al. A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation. Contraception 36 (1987) 441-457
17. Toh Y.C., Jain J., Rahnny M.H., Bode F.R., and Ross D. Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women. Clin Ther 26 (2004) 1845-1854
18. Jain J., Dutton C., Nicosia A., Wajszczuk C., Bode F.R., and Mishell Jr. D.R. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception 70 (2004) 11-18
19. Pardthaisong T. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis. J Biosoc Sci 16 (1984) 23-34
20. Pardthaisong T., Gray R.H., and McDaniel E.B. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand. Lancet 1 (1980) 509-512
21. Gray R.H., and Pardthaisong T. In utero exposure to steroid contraceptives and survival during infancy. Am J Epidemiol 134 (1991) 804-811
22. WHO. Exposure to DMPA in pregnancy may cause low birth weight. Prog Hum Reprod Res (1992) 2-3
23. Pardthaisong T., Yenchit C., and Gray R. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception 45 (1992) 313-324
24. Dahlberg K. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user. Int J Gynaecol Obstet 20 (1982) 43-48
25. Schwallie P.C. The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review. Contraception 23 (1981) 375-386
26. Rickert V.I., Tiezzi L., Lipshutz J., Leon J., Vaughan R.D., and Westhoff C. Depo Now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health 40 (2007) 22-28